EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported second-quarter profit of $131.8 million.

The Exton, Pennsylvania-based company said it had net income of $1.82 per share. Earnings, adjusted for restructuring costs and amortization costs, came to $1.84 per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.51 per share.

The medical device company posted revenue of $766.5 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $727.3 million.

West Pharmaceutical expects full-year earnings in the range of $6.65 to $6.85 per share, with revenue in the range of $3.04 billion to $3.06 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.